Pioneering bacterial therapy for the skin. | Pioneering bacterial therapy for the skin
AOBiome Therapeutic Pipeline
B244
Mild to moderate acne
B244
Pediatric atopic dermatitis
B244
Rosacea
B244
Allergic rhinitis
B244
Chronic wounds
D23
Keratosis pilaris
D23
Staphylococcus colonization
Discovery
Preclinical
Phase I
Phase II
Phase III
Welcome to AOBiome.
AOBiome is dedicated to advancing the science of AOB on human health. The human microbiome when subjected to modern hygienic routines selectively depletes potentially important Ammonia Oxidizing Bacteria (AOB).

Topical applications of patented and stabilized Ammonia Oxidizing Bacteria can restore the skin's microbiome and potentially impact a wide variety of human health conditions.

We conduct primary research, collaborate with others on research and develop applications to positively impact skin conditions,reduce inflammation and risk of infection.